Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months

Author： Forleo-Neto E. Carvalho E.S. Fuentes I.C.P. Precivale M.S. Forleo L.H.A. Farhat C.K.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.17, 1997-12, pp. : 1898-1901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite

Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection

By Cilla G. Pena B. Marimon J.M. Perez-Trallero E.

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 492-494

Elsevier

Access to resources Recommend Favorite

Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

By Boulianne N. De Serres G. Duval B. Ratnam S. Ward B.J. Joly J.R.

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1611-1616

Elsevier

Access to resources Recommend Favorite

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age

By Ceyhan M. Kanra G. Erdem G. Kanra B.

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4473-4478

Elsevier

Access to resources Recommend Favorite

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G. Gay N.J. Hesketh L.M. Vyse A. Morgan-Capner P. Brown D.W. Litton P. Miller E.

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite